Member Info for HedgeHogarth

The market moves in mysterious ways....
This share price is SIGNIFICANTLY undervalued right now:
Based on (1) The current NAV and (2) the value of its publicly quoted investments which are also not being favourably valued right now. This will change in time

Pumpky spends all his /her time on the Playbus

Dev defaulted, not KDNC. I do not see their being any consequences providing Dev quickly agree new terms. It is not in the interest of the creditors to throw a spanner into the works.
Besides, the positive far outweighs the negative here
If it does cause a drop, then there will be a very juicy buying opportunity for new investors

Apologies Laserbrain - glad to hear you are not Stu.

May i wish you the best of luck with your investment here. SHould be exciting times

Is it just me or Laserbrain a carbon copy of Stu? Anyway moving on.......

Taken from RNS on 29th Sept 2022. (After reading this, I'm sure you would agree that there is no need to RNS about a meeting with FDA - they have clearly articulated formal engagement with FDA. No need to have to tell investors that they have had a meeting with FDA - they had already said they were in the final stages 5 months ago. It's also fair to say that it has been voiced that the PQ runs were the last big step)

HEMO-CAR-T, a CAR-T therapy targeting Acute Myeloid Leukaemia ("AML"), is our lead product candidate, the intellectual property and development of which are in the Company's sole control. We have been working toward completing the necessary IND application for HEMO-CAR-T, having held detailed discussions with the US Federal Drug Administration ("FDA") during the period and received constructive feedback through a pre-IND submission that confirmed our development process and our proposals for clinical trials. Most of the data required for the IND application has been compiled and the components for manufacturing HEMO-CAR-T have been produced. We are now engaged in the final stages of establishing the production of HEMO-CAR-T cells for the treatment of patients. We are confident of completing the IND application in the near future and are working on detailed protocols for carrying out clinical trials.

The work is necessarily very detailed as the main concern in the process is to ensure patients' safety, which requires great care on the FDA's part and of course ours. We have been working with a group of Key Opinion Leaders in the treatment of acute leukaemias that has helped us to hone our approach to clinical trials. We are now in the process of finalising our trial protocol, which will involve a relationship with at least one major hospital, likely to include the University of Pennsylvania with whom we already have a working arrangement.

Hemo SP is up over 50% YTD
SP has been rock solid at 2.3p for a month now. A great sign
I have no doubt that when news comes, it will be positive and it will be a catalyst for a re-rate
It may not be even be the next RNS, it may be a combination of multipl RNS in the next few weeks/months

As Yoda might say: News flow, Hemo grow....

Strange price action here - seems to be moving down on very little volume

Ofcourse JHFH, you are spot on

However, it does not matter what you say to Pumpky; Pumpky will post the same old drivel every day finding any possible angle to project an negative stance.

So, i just told Pumpky what they want to hear

I'm sure you are correct Pumpky. I've not seen anything and we'd be fools to make the silly mistake of trying to read into tweets which are just personal

Yahoo!, This is for you, Stu.... xxx

surprise
/s?'pr??z/
noun
1.an unexpected or astonishing event, fact, etc.
"the announcement came as a complete surprise"

Perhaps Mr 1m buyer knows something we all don't?
Or maybe Mr 750k seller does?
Who knows, eh?

Stu - You are welcome to have you own theories on when an RNS may land.
However, we don't really know when it will. I was hoping we would have news this week.
So as some of the posters who are more intelligent than me have suggested, lets stop worrying about when an RNS lands
It you invest in HEMO, i suggest you are confident in the direction of travel right now, without needed an RNS in the next 5 mins to convince you

Almost like clockwork - a morning snipe from Pumpky
If only your trading profits were as predictable (just teasing)
Have a good weekend

OR....
sometimes savvy and smart investors will less things settle for a day or so after a positive RNS, lets the bears dive in and then make their move - seen that on a number of occasions work a treat

BB - the behaviour you describe is fair - but only really the behaviour of small time traders and PIs. The Big boys however, you we hope will take an interest in #HEMO when the time is right will act on news that flows. It can take a little while to fill bigger orders .

ATM, only a few IIs would look at 'HEMO and only for specialist niche funds (Micro Caps, small Biotechs). This will change if HEMO make progress towards the clinic and the mCap increases. Formal partnerships with big pharma will also help it grab the limelight

Let's hope the sells today belonged to Pumpky; and the RNS lands tomorrow ;-)

Exciting times manifesto ??

Fingers crossed.
Getting tired of Stu's constant, manipulative messages on here trying to sow the seeds of doubt.

Fortunately, trying to dampen the enthusiasm in respect of the progress made, the news imminent and the rich potential is like betting against Usain Bolt I'm his prime.

So Stu, I would suggest you give up now and go and talk another stock down.

I checked back to December and could not see it

Stu - with respect, your last post comes across very childish

" You said this, i said that...."

"I'm right, I'm right" "You're wrong, you;re wrong"

Please grow up and act more maturely

I did not see any tweet from Vlad talking about March / April??? Can you give me the link

Just looking through his tweets this year. He did tweet "That is correct. The next step is 12-24 hours process" on Jan 20th which may explain some of the work they are doing.

Aseptic processing, as i understand it, is a superior process for sterilisation (Vs terminal sterilization). I understand it to be quicker, cheaper and safer. The FDA do not insist on it and cannot legally enforce it, but why wouldn't you go down this route. My suspicion is that may be what has been going on - Hemo's tweet suggest it is about taking CaR-T into the clinic safely.